Fda declines to approve adamis pharmaceuticals drug zimhi

Adamis pharmaceuticals receives a complete response letter from the fda regarding zimhi.adamis pharmaceuticals corp - questions raised by fda in crl regarding zimhi related generally to chemistry, manufacturing and controls.adamis pharmaceuticals corp - plan to expand on cmc testing for zimhi has already been provided to fda to satisfy crl items.adamis pharmaceuticals corp - no other clinical safety or efficacy issues were raised by fda regarding zimhi.adamis pharmaceuticals corp - new drug application for zimhi will remain open until cmc issues are resolved.
ADMP Ratings Summary
ADMP Quant Ranking